On August 15, 2024, Mangoceuticals, Inc., also known as MangoRx, reported substantial growth in its financial results for the first half of 2024. The company, which specializes in men's health and wellness products, including treatments for erectile dysfunction, hair growth, weight loss, and hormone replacement therapies, disclosed a 1,685% increase in shareholders' equity and a 56% increase in year-over-year revenue. Shareholders' equity surged to $13.8 million, up from $774,754 at the end of the previous year, largely due to the acquisition of a patent portfolio from Intramont Technologies. Revenue for the six months ended June 30, 2024, reached $377,258, with a gross profit of $217,190, marking significant growth from the same period in the previous year. CEO Jacob Cohen highlighted the company's focus on innovation and customer...Show More

On August 15, 2024, Mangoceuticals, Inc., also known as MangoRx, reported substantial growth in its financial results for the first half of 2024. The company, which specializes in men's health and wellness products, including treatments for erectile dysfunction, hair growth, weight loss, and hormone replacement therapies, disclosed a 1,685% increase in shareholders' equity and a 56% increase in year-over-year revenue. Shareholders' equity surged to $13.8 million, up from $774,754 at the end of the previous year, largely due to the acquisition of a patent portfolio from Intramont Technologies. Revenue for the six months ended June 30, 2024, reached $377,258, with a gross profit of $217,190, marking significant growth from the same period in the previous year. CEO Jacob Cohen highlighted the company's focus on innovation and customer satisfaction, with expectations for continued growth in the latter half of the year. MangoRx is also preparing to launch new products, including compounded oral dissolvable tablet (ODT) GLP-1 inhibitors for weight loss and a hormone therapy product for low testosterone. The company's telemedicine platform facilitates the prescription and delivery of its products directly to consumers.